5/1/2013

The FDA has cleared NovoSource to market its NovoKnee system, which is tailored for use by orthopedic doctors in performing total-joint-replacement surgeries for the knee. The device is meant to provide a lower-cost implant and cut medical expenses for orthopedic patients.

Related Summaries